acut
exacerb
chronic
obstruct
pulmonari
diseas
cameron
et
al
investig
possibl
role
virus
episod
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
use
modern
diagnost
test
includ
immunofluoresc
assay
polymeras
chain
reaction
nasopharyng
aspir
identifi
infect
case
virus
probabl
respons
pathogen
influenza
type
rhinoviru
common
organ
bacteria
found
case
haemophilu
influenza
common
pathogen
author
fail
find
signific
differ
clinic
characterist
outcom
virusinfect
noninfect
patient
relat
editori
luyt
comment
gener
viru
intens
care
unit
icu
patient
emphas
question
relationship
viral
diseas
outcom
doubt
reliabl
modern
diagnost
test
risk
falseposit
result
consequ
relev
viral
detect
respiratori
tract
secret
detect
viru
mean
infect
base
use
chest
radiographi
andor
ultrasound
tu
et
al
studi
febril
medic
icu
patient
pleural
effus
thoracentesi
found
patient
complic
parapneumon
effus
empyema
presumpt
caus
complic
infect
pleural
effus
hospitalacquir
pneumonia
communityacquir
pneumonia
primari
empyema
cultur
posit
case
isol
anaerob
candida
speci
found
less
case
among
patient
posit
cultur
nontubercul
effus
receiv
initi
inadequ
antibiot
treatment
mortal
rate
vs
patient
whose
treatment
adequ
data
confirm
complic
parapneumon
effus
empyema
sever
diseas
medic
icu
patient
inadequ
initi
antimicrobi
therapi
import
prognost
factor
retrospect
studi
conduct
one
icu
hong
kong
receiv
patient
confirm
suspect
sever
acut
respiratori
syndrom
sar
gomersal
et
al
describ
transmiss
sar
healthcar
worker
doctor
nurs
studi
period
patient
admit
icu
median
length
icu
stay
day
rigor
appli
infect
control
procedur
five
icu
staff
member
four
nurs
one
healthcar
assist
develop
sar
despit
long
staff
exposur
time
h
doctor
h
nurs
substandard
physic
architectur
environ
three
five
case
occur
earli
outbreak
within
day
admiss
first
patient
sar
suggest
infect
control
procedur
must
appli
rigor
start
epidem
thu
risk
healthcar
worker
acquir
sar
low
rapid
immunochromatograph
membran
test
ict
new
streptococcu
pneumonia
urinari
antigen
assay
studi
popul
icu
patient
without
communityacquir
pneumonia
cap
pneumococc
cap
nonpneumococc
cap
ict
posit
patient
pneumococc
cap
patient
nonpneumococc
cap
none
patient
without
cap
sensit
specif
posit
neg
predict
valu
respect
among
patient
receiv
prior
antibiot
therapi
oper
characterist
ict
modifi
result
report
lasocki
et
al
compar
observ
outpati
nonicu
inpati
permit
definit
conclus
regard
clinic
interest
impact
diagnost
techniqu
manag
patient
sever
cap
maxillari
sinus
frequent
complic
occur
intub
patient
often
underestim
underdiagnos
systemat
search
treatment
nosocomi
maxillari
sinus
nm
discuss
prevent
occurr
ventilatorassoci
pneumonia
prospect
openlabel
random
studi
conduct
multipl
trauma
patient
expect
mechan
ventil
day
design
investig
efficaci
local
appli
nasal
decongest
agent
xylometazolin
corticosteroid
budesonid
prevent
nm
compar
placebo
group
patient
receiv
topic
treatment
less
frequent
develop
radiolog
maxillari
sinus
vs
p
contrast
incid
infecti
maxillari
sinus
vs
p
vap
vs
ns
significantli
differ
first
clinic
evalu
suggest
use
pharmacolog
agent
reduc
inflamm
may
benefici
effect
prevent
maxillari
sinus
howev
data
report
pneumatiko
et
al
difficult
recommend
practic
routin
prevent
strategi
mechan
ventil
patient
diagnosi
nm
icu
patient
treat
mechan
ventil
mv
usual
base
computer
tomographi
ct
isol
organ
materi
obtain
transnas
punctur
avoid
transport
patient
outsid
icu
transnas
punctur
base
sinu
echographi
merit
valuat
end
varga
et
al
conduct
prospect
studi
patient
clinic
suspicion
maxillari
sinus
sinus
examin
definit
posit
echographi
visual
hyperechogen
posterior
wall
sinu
associ
extens
intern
extern
wall
sinu
sinu
ultrasound
posit
transnas
punctur
perform
consid
posit
fluid
obtain
sinu
aspir
studi
design
evalu
valu
echographi
obtain
posit
transnas
punctur
sinu
ultrasound
posit
case
transnas
punctur
posit
hand
sinu
ultrasound
neg
sinus
observ
ct
studi
suggest
transnas
punctur
could
perform
directli
result
sinu
echographi
howev
echograph
examin
sinu
ultrasound
operatordepend
thu
gener
precis
descript
standard
procedur
specif
popul
mechan
ventil
patient
must
specifi
consider
evid
suggest
specif
intervent
effect
employ
prevent
ventilatorassoci
pneumonia
vap
measur
prevent
vap
extend
aspect
daili
intens
care
practic
includ
oral
care
suction
respiratori
secret
mori
et
al
studi
whether
oral
care
contribut
prevent
vap
compar
patient
receiv
oral
care
histor
control
oral
care
nurs
plan
includ
follow
protocol
three
time
daili
suction
oropharyng
secret
increas
cuff
pressur
posit
patient
head
side
assess
condit
soft
hand
tissu
oral
caviti
cleans
oral
caviti
use
swab
soak
dilut
povidoneiodin
gargl
cleans
oral
caviti
use
tooth
brush
rins
ml
weakli
acid
water
repeat
cleans
povidoneiodinesoak
swab
suction
oral
caviti
portion
trachea
cuff
follow
restor
cuff
pressur
protocol
incid
vap
decreas
control
group
oral
care
group
particular
case
earlyonset
vap
vap
occur
within
h
start
mv
onetenth
observ
nonor
care
group
differ
observ
outcom
variabl
unfortun
studi
evalu
nonpharmacolog
simpl
measur
conduct
period
introduct
new
method
prevent
vap
semirecumb
posit
subglott
secret
drainag
close
tracheal
suction
devic
nonus
introduc
confound
effect
long
studi
period
result
studi
confirm
import
impact
oral
care
occurr
vap
suggest
variabl
control
studi
evalu
pharmacolog
nonpharmacolog
prophylact
measur
particularli
case
multicentr
trial
three
articl
dedic
modal
endotrach
suction
prevent
vap
one
costefficaci
analysi
relat
editori
one
metaanalysi
lorent
et
al
compar
tracheal
suction
cost
incid
vap
use
close
system
without
daili
chang
versu
open
tracheal
suction
system
random
studi
conduct
patient
differ
incid
vs
incidencedens
per
day
vs
per
day
mv
vap
tracheal
suction
cost
per
patientday
vs
euro
howev
patient
treat
mv
day
use
close
system
without
daili
chang
associ
lower
cost
editori
maggior
stress
limit
studi
larg
proport
patient
treat
mv
less
day
variabl
cost
open
close
system
depend
manufactur
countri
absenc
effect
type
suction
system
incid
vap
vonberg
et
al
confirm
data
metaanalysi
random
control
trial
select
nine
trial
includ
patient
open
suction
group
close
suction
group
twenti
per
cent
patient
treat
open
system
patient
treat
close
system
develop
vap
thu
pool
rel
risk
close
suction
system
ci
today
potenti
risk
benefit
close
suction
system
theoret
base
control
evalu
efficaci
suction
possibl
impact
occurr
tracheal
tube
obstruct
atelectasi
increas
work
breath
vs
possibl
decreas
bacteri
contamin
caregiv
potenti
associ
crosstransmiss
occurr
exogen
pneumonia
venstein
et
al
propos
algorithm
base
direct
examin
endotrach
aspir
andor
protect
telescop
cathet
specimen
altern
wellknown
clinic
bacteriolog
approach
observ
studi
conduct
patient
suspect
vap
retrospect
found
overal
rate
appropri
manag
base
comparison
result
protect
specimen
consid
result
good
consequ
suggest
clinicobacteriolog
strategi
may
one
simpl
way
correctli
diagnos
vap
improv
therapeut
decis
howev
true
immedi
longterm
impact
algorithm
describ
articl
merit
evalu
strategi
appropri
prevent
resort
broadspectrum
drug
coverag
larg
major
patient
develop
sign
symptom
suggest
pneumonia
thu
minim
emerg
resist
flora
redirect
search
anoth
infect
site
two
studi
conduct
specif
popul
icu
patient
develop
vap
orlikowski
et
al
analys
prognosi
pneumonia
cohort
patient
guillainbarr
syndrom
treat
mv
fortyeight
earlyonset
day
lateonset
day
pneumonia
antibiot
select
empir
adjust
accord
microbiolog
result
empir
regimen
prove
adequ
case
time
day
admiss
ventil
variabl
independ
associ
occurr
earlyonset
pneumonia
moreov
chiefli
relat
aspir
microbiolog
characterist
earlyonset
pneumonia
e
high
frequenc
polymicrobi
pneumonia
identifi
respons
pathogen
confirm
high
risk
aspir
pneumonia
popul
observ
mortal
rate
comb
et
al
conduct
studi
establish
accur
impact
piperacillin
resist
outcom
pseudomona
vap
patient
receiv
appropri
empir
antibiot
base
patient
p
aeruginosa
pneumonia
includ
random
trial
compar
two
durat
treatment
author
demonstr
patient
piperacillinresist
pseudomona
strain
higher
mortal
suscept
strain
vs
p
howev
age
femal
gender
sever
ill
sofa
score
sever
underli
comorbid
identifi
associ
mortal
multivari
analysi
piperacillin
resist
morbid
variabl
durat
mv
icu
stay
well
vap
recurr
rate
differ
resist
suscept
strain
studi
confirm
difficulti
encount
correctli
evalu
mortal
morbid
directli
attribut
develop
vap
howev
strongli
underlin
patient
vap
due
resist
strain
benefit
appropri
empir
therapi
earli
identif
treatment
patient
vap
due
antibioticresist
strain
mean
appropri
diagnost
strategi
identif
risk
factor
resist
knowledg
bacteri
ecolog
icu
patient
hospit
confirm
utmost
import
sepsi
definit
prevent
cost
sever
studi
variou
european
countri
document
rate
system
inflammatori
respons
syndrom
sir
sepsi
icu
patient
associ
outcom
howev
sir
criteria
criticis
frequenc
lack
specif
soap
studi
evalu
prospect
studi
conduct
icu
european
countri
includ
admiss
high
proport
patient
sir
time
icu
stay
presenc
sir
criteria
associ
higher
risk
develop
sever
sepsi
shock
correl
organ
failur
mortal
studi
confirm
prognost
import
sir
especi
criteria
present
addit
biochem
marker
clinic
sign
sir
consid
enhanc
diagnost
specif
syndrom
suggest
piro
system
creactiv
protein
crp
one
marker
howev
patient
liver
dysfunct
may
mount
adequ
crp
respons
infect
shown
mackenzi
woodhous
found
bacteraem
patient
lower
serum
crp
level
median
mgl
associ
liver
dysfunct
counterpart
without
dysfunct
mgl
serum
crp
concentr
may
thu
unreli
diagnosi
monitor
bacteri
sepsi
patient
liver
diseas
statin
appear
broad
immunomodulatori
antiinflammatori
effect
sever
recent
retrospect
cohort
studi
suggest
reduc
rate
sever
infect
may
associ
statin
therapi
prior
occurr
infect
kruger
et
al
analys
cohort
patient
bacteraemia
receiv
statin
therapi
allcaus
hospit
mortal
vs
p
death
attribut
bacteraemia
vs
p
lower
patient
receiv
statin
therapi
reduct
persist
adjust
imbal
appar
patient
continu
receiv
statin
therapi
diagnosi
bacteraemia
n
comment
upon
accompani
editori
studi
add
grow
list
paper
suggest
benefit
statin
therapi
sepsi
call
random
trial
statin
therapi
sepsi
rel
larg
studi
italian
givitti
databas
rossi
et
al
examin
variat
cost
hospit
viewpoint
outcom
across
variou
diagnost
group
icu
patient
cost
includ
length
icu
stay
cost
euro
diagnost
therapeut
procedur
drug
equip
use
consult
physician
unit
cost
per
surviv
patient
mostli
determin
length
stay
higher
aliard
nontraumat
intracrani
haemorrhag
multipl
trauma
emerg
abdomin
surgeri
wherea
loss
expenditur
patient
diedtot
number
patient
higher
aliard
lower
multipl
trauma
plan
coronari
major
abdomin
surgeri
shortstay
patient
appear
costeffici
author
conclud
cost
treatment
icu
vari
wide
differ
type
patient
studi
address
major
determin
high
cost
low
costeffici
simplifi
method
accur
surveil
infect
sought
determin
whether
dipstick
method
could
help
predict
urinari
tract
infect
catheter
icu
patient
schwartz
baron
collect
urin
sampl
surgic
icu
patient
compar
dipstick
urinalysi
find
subsequ
quantit
cultur
result
presenc
nitrit
dipstick
urinalysi
best
indic
infect
specif
poor
sensit
posit
neg
likelihood
ratio
respect
dipstick
urinalysi
reli
screen
potenti
catheterassoci
urinari
tract
infect
optim
antimicrobi
dose
especi
avoid
underdos
import
goal
achiev
effect
therapi
prevent
emerg
resist
may
especi
difficult
achiev
continu
venoven
haemofiltr
cvvh
predict
dose
dose
interv
bouman
et
al
compar
observ
cvvh
clearanc
variou
antibiot
valu
predict
fraction
unbound
protein
siev
rate
sc
ultrafiltr
rate
patient
cvvh
found
amoxicillin
ceftazidim
ciprofloxacin
fluconazol
metronidazol
vancomycin
easili
filter
mean
sc
flucloxacillin
mean
sc
differ
observ
predict
mainten
dose
small
drug
except
ceftazidim
vancomycin
author
conclud
predict
cvvh
remov
provid
reliabl
estim
dose
antibiot
except
narrow
therapeut
index
predominantli
renal
clearanc
eg
vancomycin
cycl
rotat
antibiot
advoc
reduc
risk
emerg
select
bacteri
resist
frequenc
cycl
unclear
prospect
studi
one
icu
dama
et
al
examin
effect
rotat
antibiot
within
three
subunit
use
three
differ
empir
regimen
month
signific
chang
overal
antibiot
suscept
observ
period
howev
concomit
decreas
suscept
sever
speci
observ
antibiot
use
firstlin
therapi
unit
author
conclud
homogen
antibiot
use
period
sever
month
induc
bacteri
resist
common
pathogen
assess
distribut
bacteri
speci
potenti
risk
antimicrobi
resist
longterm
use
select
digest
decontamin
sdd
heineg
et
al
examin
data
period
icu
routin
use
sdd
togeth
search
destroy
strategi
methicillinresist
staphylococcu
aureu
mrsa
compar
averag
record
within
german
icu
surveil
system
sari
overal
patient
admiss
receiv
sdd
colistin
tobramycin
amphotericin
b
resist
rate
remain
low
period
whether
mrsa
patientday
aminoglycosid
resist
pseudomona
aeruginosa
patientday
well
sari
averag
patientday
respect
howev
rel
frequenc
enterococci
coagulaseneg
staphylococci
cn
higher
sari
vs
vs
respect
author
conclud
routin
use
sdd
associ
increas
antimicrobi
resist
icu
low
baselin
resist
rate
vigor
control
program
although
rel
increas
enterococci
cn
concern
hemodynam
oxygen
hemodynam
coagul
monitor
mix
venou
oxygen
content
reflect
relationship
wholebodi
oxygen
consumpt
cardiac
output
condit
constant
arteri
oxygen
content
sinc
physic
dissolv
oxygen
reflect
partial
venou
oxygen
pressur
neglect
haemoglobin
might
remain
constant
period
time
measur
svo
could
use
paramet
abl
describ
peripher
oxygen
svo
measur
necessit
insert
pulmonari
arteri
cathet
consid
costli
invas
procedur
altern
measur
scvo
commerci
avail
fibreopt
cathet
suggest
healthi
subject
oxygen
satur
inferior
vena
cava
higher
superior
vena
cava
thu
svo
superior
scvo
contrast
critic
ill
patient
scvo
superior
svo
sinc
inferior
vena
cava
satur
lower
scvo
cardiocirculatori
shock
andor
anaesthesia
latter
procedur
reduc
cerebr
oxygen
extract
increas
cerebr
blood
flow
thu
increas
scvo
despit
discrep
use
scvo
suggest
surrog
svo
contradictori
result
report
indic
high
correl
coeffici
scvo
svo
variou
condit
studi
report
lack
equival
scvo
svo
even
accord
physiolog
precis
determin
svo
scvo
unlik
mani
author
report
parallel
track
svo
scvo
differ
patholog
condit
lastli
earli
goalori
therapi
maintain
scvo
first
h
shown
reduc
mortal
among
patient
sever
sepsi
septic
shock
aim
studi
perform
varpula
et
al
assess
initi
resuscit
correl
agreement
svo
scvo
compar
scvo
svo
differ
lactat
oxygenderiv
haemodynam
paramet
earli
septic
shock
icu
septic
shock
patient
receiv
norepinephrin
author
demonstr
mean
svo
alway
mean
scvo
bia
differ
scvo
svo
limit
agreement
rang
scvo
svo
differ
close
significantli
correl
cardiac
index
oxygen
transport
varpula
et
al
also
demonstr
chang
scvo
svo
parallel
two
success
measur
studi
suggest
scvo
could
use
instead
svo
guid
treatment
septic
shock
icu
patient
contrast
result
report
emerg
depart
earli
hypovolaem
phase
sever
sepsi
septic
shock
author
conclud
use
scvo
guid
septic
shock
treatment
icu
patient
need
evalu
prospect
multicentr
random
trial
sever
recent
studi
emphas
valu
respiratori
variat
surrog
stroke
volum
sv
predict
preload
respons
mechan
ventil
patient
confirm
mvinduc
pulsepressur
variat
could
consequ
mvinduc
sv
variat
need
technolog
allow
acquisit
beatbybeat
sv
valu
two
modal
develop
valid
purpos
e
oesophag
doppler
puls
contour
cardiac
output
pcco
although
techniqu
report
beattobeat
chang
sv
neither
shown
accur
measur
beattobeat
chang
sv
rather
steadyst
cardiac
output
averag
time
gunn
et
al
experiment
studi
includ
small
popul
five
purposebr
research
hound
test
abil
two
techniqu
predict
absolut
chang
sv
determin
one
two
gold
standard
aortic
root
flow
probe
conduct
cathet
gave
estim
left
ventricl
sv
differ
measur
maxim
minim
left
ventricl
volum
author
demonstr
given
haemodynam
state
studi
baselin
norepinephrin
nitroprussid
dobutamin
oesophag
doppler
monitoringderiv
stroke
distanc
pcco
deriv
sv
accur
follow
direct
chang
aortic
flow
probederiv
sv
howev
two
techniqu
estim
consist
absolut
sv
valu
track
proport
chang
sv
compar
aortic
flow
probe
determin
gunn
et
al
suggest
two
devic
chang
relationship
sv
cardiovascular
state
vari
oesophag
doppler
monitor
chang
could
link
chang
distribut
flow
upper
lower
arteri
circuit
andor
onset
non
develop
laminar
flow
pcco
devic
threeelement
windkessel
model
use
determin
sv
could
erron
arteri
tone
myocardi
contractil
vari
paper
suffer
mani
methodolog
limit
suggest
studi
appropri
wellvalid
design
confirm
refut
potenti
limit
howev
experiment
studi
preclud
use
two
techniqu
assess
fluid
respons
critic
ill
patient
sinc
volum
expans
signific
influenc
arteri
tone
cardiac
contractil
blood
flow
redistribut
abl
induc
measur
error
determin
absolut
valu
sv
thu
two
beatbybeat
sv
determin
techniqu
remain
pertin
evalu
fluid
respons
mechan
ventil
critic
ill
patient
predict
onset
cardiogen
pulmonari
oedema
may
also
requir
sensit
monitor
techniqu
schochat
colleagu
assess
valu
intern
thorac
imped
monitor
predict
cardiogen
pulmonari
oedema
patient
risk
examin
consecut
patient
clinic
sign
pulmonari
oedema
extracardiac
respiratori
failur
pacemak
patient
admit
cardiac
condit
monitor
lung
electr
imped
use
predict
cardiogen
pulmonari
oedema
sinc
accumul
blood
fluid
decreas
imped
valu
thirtyseven
patient
develop
cardiogen
pulmonari
oedema
monitor
intern
thorac
imped
decreas
baselin
author
suggest
preliminari
studi
monitor
may
suitabl
earli
predict
cardiogen
pulmonari
oedema
appear
clinic
sign
anoth
import
monitor
aspect
concern
coagul
cardiac
surgeri
merlani
colleagu
determin
activ
partial
thromboplastin
time
aptt
coagul
manag
heart
surgeri
use
pointofcar
poc
aptt
determin
random
patient
plan
valv
surgeri
coronari
arteri
bypass
graft
cardiopulmonari
bypass
postop
coagul
manag
monitor
either
central
laboratori
aptt
poc
aptt
heparin
administ
accord
guidelin
patient
valv
poc
group
time
desir
coagul
state
reduc
thorac
blood
loss
reduc
number
patient
receiv
transfus
improv
observ
coronari
arteri
bypass
group
side
effect
similar
two
group
colloidcrystalloid
controversi
refer
debat
respect
merit
demerit
infus
colloid
crystalloid
solut
patient
suffer
hypovolaem
hypotens
even
though
recent
safe
studi
albumin
versu
salin
fluid
resuscit
report
signific
superior
albumin
regard
outcom
critic
ill
patient
increas
data
suggest
renal
toxic
sever
advers
effect
colloid
respect
amplitud
cardiac
respons
follow
colloid
salin
administr
remain
subject
controversi
verheij
et
al
studi
effect
volum
expans
myocardi
function
colloid
crystalloid
treatment
hypovolaemia
cardiac
major
vascular
surgeri
use
fluid
challeng
protocol
modifi
weil
et
al
author
compar
randomli
assign
patient
cardiac
respons
follow
fluid
challeng
salin
colloid
gelatin
hydroxyethylstarch
albumin
reach
object
signific
larger
infus
salin
ml
colloid
ml
requir
associ
signific
decreas
colloid
osmot
pressur
salin
group
signific
increas
plasma
volum
colloid
group
vs
colloid
infus
induc
larger
signific
increas
cardiac
index
stroke
work
index
salin
infus
without
differ
colloid
group
verheij
et
al
suggest
differ
fluid
respons
crystalloid
colloid
fluid
refer
differ
cardiac
fill
rather
cardiac
function
studi
lack
chang
slope
relationship
fill
pressur
global
enddiastol
volum
index
suggest
differ
myocardi
complianc
among
group
even
though
colloid
osmot
pressur
higher
colloid
group
lastli
might
emphas
whatev
group
increas
mean
arteri
pressur
similar
could
suggest
observ
differ
colloid
salin
solut
offset
studi
increas
amount
infus
salin
solut
sinc
observ
differ
concern
cardiac
fill
rather
cardiac
function
must
also
kept
mind
whatev
choic
colloid
crystalloid
three
main
principl
might
guid
clinician
start
earli
possibl
administr
volum
expans
control
efficaci
volum
expans
predefin
goalori
therapi
care
potenti
onset
sever
advers
effect
cardiac
arrest
mechan
ventil
emerg
team
adequ
ventil
essenti
success
resuscit
cardiac
arrest
manag
remain
debat
constant
flow
insuffl
oxygen
cfio
rate
lmin
via
capillari
insert
wall
endotrach
boussignac
tube
previous
report
purpos
sinc
chest
compress
gener
suffici
ventil
achiev
correct
ga
exchang
bertrand
et
al
prospect
multicentr
random
clinic
trial
assign
patient
resuscit
outofhospit
cardiac
arrest
either
standard
endotrach
intub
mv
use
cfio
flow
rate
lmin
due
methodolog
problem
met
studi
desper
prognosi
cohort
patient
select
nonrespond
initi
defibril
trial
must
seen
primarili
effect
studi
sinc
suffer
lack
power
bertrand
et
al
report
signific
differ
outcom
regard
return
spontan
ventil
cfio
vs
mv
hospit
admiss
vs
icu
discharg
vs
main
find
studi
concern
improv
detect
spo
patient
ventil
cfio
exact
mechan
observ
need
clarif
even
relationship
signific
increas
surviv
demonstr
howev
observ
suggest
peripher
circul
oxygen
improv
cfio
convent
mv
lastli
lower
incid
rib
cage
fractur
observ
cfio
group
increas
pulmonari
volum
intrathorac
pressur
cfio
could
attenu
chest
wall
injuri
secondari
chest
massag
cfio
appear
safe
method
provid
ventil
cardiopulmonari
resuscit
could
use
instead
convent
mv
mv
devic
avail
lellouch
et
al
examin
problem
airway
humidif
induc
hypothermia
cardiac
arrest
prospect
crossov
random
studi
nine
adult
patient
hospit
cardiac
arrest
lellouch
colleagu
assess
efficaci
differ
humidif
devic
induct
moder
hypothermia
h
patient
randomli
ventil
hypothermia
heat
moistur
exchang
heat
humidifi
activ
heat
moistur
exchang
system
demonstr
limit
moder
hypothermia
heat
moistur
exchang
led
major
underhumidif
absolut
humid
mgh
ol
use
caution
heat
humidifi
mostli
adequ
led
overhumidif
case
current
recommend
set
retrospect
observ
studi
cardiac
arrest
involv
ward
patient
author
describ
time
cardiac
arrest
detect
relat
episod
medic
emerg
team
met
review
routin
nurs
observ
peak
level
cardiac
arrest
detect
occur
time
routin
overnight
nurs
clinic
observ
introduct
met
invers
link
detect
cardiac
arrest
level
met
activ
period
author
conclud
favour
increas
overnight
util
earlier
met
activ
order
reduc
incid
cardiac
arrest
brugada
syndrom
character
st
segment
elev
right
precordi
lead
associ
presenc
right
bundl
branch
block
rare
famili
entiti
autosom
domin
inherit
variabl
express
ecg
aspect
observ
occasion
patient
myocardi
infarct
pulmonari
embol
cocain
psychotrop
drug
overdosag
montebankooistra
et
al
retrospect
studi
electrocardiograph
indic
toxic
patient
admit
tricycl
antidepress
overdos
period
observ
brugadalik
pattern
six
patient
two
death
resolv
quickli
sodium
bicarbon
administr
due
retrospect
design
studi
small
number
patient
possibl
determin
whether
brugada
pattern
explain
sever
intox
synergist
effect
ingest
medic
increas
sensit
patient
classic
frequent
observ
intraventricular
conduct
disturb
administr
sodium
bicarbon
requir
rapidli
efficaci
diagnosi
brugada
pattern
set
poison
tricycl
antidepress
reason
perform
flecainid
test
diagnos
true
covert
brugada
syndrom
qt
prolong
drug
overdos
may
expos
patient
lifethreaten
arrhythmia
may
need
specif
therapi
reason
isbist
et
al
develop
guidelin
manag
qt
prolong
citalopram
overdos
includ
decontamin
activ
charcoal
cardiac
monitor
base
simul
studi
use
previous
develop
pharmacokineticpharmacodynam
model
predict
timecours
qt
prolong
effect
citalopram
dose
use
therapi
model
may
help
clinician
decid
patient
decontamin
monitor
articl
later
discuss
journal
among
arrhythmia
record
icu
atrial
fibril
af
wide
observ
preval
af
icu
much
higher
gener
popul
even
incid
heterogen
highli
depend
underli
condit
patient
e
cardiac
patient
age
sever
ill
assess
sap
ii
ssir
etc
mani
factor
could
explain
onset
af
icu
patient
hypovolaemia
hypoxia
electrolyt
disord
especi
dyskaliaemia
stress
pain
anxieti
seguin
et
al
report
prospect
observ
studi
evalu
incid
risk
factor
af
trauma
patient
requir
surgic
intens
care
manag
popul
observ
occurr
af
onset
af
median
day
potassium
troponin
level
differ
patient
without
af
patient
suffer
af
receiv
fluid
catecholamin
suffer
frequent
septic
shock
multivari
analysi
interpret
caution
low
incid
outcom
event
suggest
five
independ
risk
factor
develop
af
catecholamin
sap
age
year
presenc
sir
three
traumat
region
although
hospit
mortal
twice
high
af
group
vs
differ
signific
sustain
af
develop
icu
patient
whatev
aetiolog
anticoagul
unfract
heparin
mandatori
unless
contraind
contrast
need
antiarrhythm
agent
cardiovers
might
discuss
correct
underli
disord
hypovolaemia
switch
inotrop
vasopress
agent
echocardiograph
evalu
elderli
popul
grow
develop
countri
hospit
icu
earli
year
twentyfirst
centuri
patient
year
old
repres
vs
late
icu
patient
year
old
strong
variabl
studi
admiss
polici
demograph
context
group
patient
age
year
older
de
rooij
et
al
distinguish
unplan
surgic
unplan
medic
plan
surgic
admiss
found
icu
mortal
respect
month
hospit
discharg
observ
mortal
rate
addit
median
surviv
plan
surgic
patient
differ
surviv
observ
age
group
gener
popul
independ
risk
factor
icu
mortal
variabl
reflect
sever
ill
alter
renal
function
independ
risk
factor
mortal
torr
et
al
evalu
shortand
longterm
outcom
patient
year
old
treat
intermedi
care
unit
patient
admit
emerg
depart
acut
hospit
ward
icu
directli
hospit
requir
highdepend
care
monitor
inotrop
agent
noninvas
ventil
arteri
venou
cathet
sever
ill
confirm
mean
apach
ii
score
point
point
without
age
point
hospit
stay
longer
mortal
higher
patient
compar
patient
year
contrast
statist
signific
differ
observ
hospit
mortal
discharg
longterm
facil
readmiss
author
confirm
sever
ill
therapeut
intervent
predictor
shortterm
mortal
wherea
comorbid
strongest
predictor
longterm
mortal
garrousteorgea
et
al
report
result
studi
evalu
triag
decis
icu
admiss
request
subsequ
outcom
patient
age
year
icu
admiss
refus
case
patient
consid
sick
benefit
well
benefit
hospit
mortal
admit
patient
group
sick
benefit
group
well
benefit
similarli
mortal
respect
selfsuffici
year
hospit
discharg
modifi
icu
stay
contrast
qualiti
life
poorer
icu
patient
sameag
gener
popul
editori
comment
three
studi
boumendil
guidet
emphas
import
sever
point
evalu
outcom
critic
ill
elderli
patient
influenc
select
bia
older
patient
good
condit
admit
icu
older
age
associ
lower
resourc
intens
lower
hospit
cost
icu
mortal
hospit
mortal
mainli
relat
diagnosi
type
admiss
initi
sever
longterm
surviv
patient
global
regain
previou
health
statu
elderli
patient
icu
major
concern
matter
debat
develop
countri
gener
age
need
barrier
icu
admiss
physician
probabl
tend
overestim
import
age
surviv
underestim
qualiti
life
elderli
survivor
avoid
underutil
icu
elderli
admiss
polici
must
better
defin
specif
need
identifi
elderli
patient
may
benefit
intens
care
final
studi
evalu
longterm
outcom
particularli
qualiti
life
cost
need
patient
famili
physician
make
decis
base
expect
outcom
patientfamili
wish
biolog
marker
collagen
deposit
degrad
surfact
inactiv
present
bronchoalveolar
lavag
fluid
balf
patient
acut
respiratori
distress
syndrom
ard
relationship
marker
elast
behaviour
respiratori
system
ard
patient
could
give
pathophysiolog
insight
syndrom
demoul
et
al
assess
relationship
complianc
measur
pressurevolum
curv
zero
cmh
biolog
marker
collagen
turnov
surfact
degrad
balf
patient
earli
ard
complianc
significantli
correl
marker
collagen
turnov
surfact
degrad
correl
stronger
pressurevolum
pv
curv
trace
cmh
author
conclud
respiratori
system
complianc
may
influenc
collagen
turnov
surfact
degrad
predict
progress
aspir
pneumon
fullblown
ard
difficult
el
solh
et
al
hypothes
alveolar
plasminogen
activ
could
identifi
patient
observ
aspir
gastric
content
risk
progress
ard
patient
wit
aspir
alveolar
fluid
sampl
perform
within
h
intub
alveolar
antigen
level
mgml
progress
ard
n
ngml
uncompl
aspir
pneumon
n
cutoff
level
alveolar
ngml
sensit
specif
predict
progress
ard
plasma
level
antigen
differ
two
group
author
conclud
alveolar
antigen
level
use
valid
biomark
progress
ard
patient
document
aspir
karagiorga
colleagu
present
interest
paper
investig
level
neutral
lipid
balf
patient
fat
embol
syndrom
fe
aliard
divers
origin
without
cardiopulmonari
diseas
total
bal
protein
fe
group
significantli
higher
aliard
alter
individu
phospholipid
class
similar
total
cholesterol
lipid
ester
monoglycerid
significantli
higher
fe
group
group
level
plateletactiv
factor
fe
significantli
higher
patient
fe
aliard
phospholipas
activ
significantli
higher
control
author
suggest
level
neutral
lipid
balf
use
distinguish
patient
fe
aliard
prospect
multicentr
observ
studi
ard
patient
requir
mv
quebec
critic
care
network
found
higher
initi
serum
concentr
clara
cell
protein
lung
epitheliumspecif
small
protein
associ
increas
risk
death
fewer
ventilatorfre
day
increas
frequenc
nonpulmonari
multipl
organ
failur
median
serum
level
significantli
higher
nonsurvivor
survivor
day
iqr
vs
sustain
day
allow
conclus
valuabl
biomark
ard
may
help
predict
outcom
among
ard
patient
high
risk
death
new
interest
predictor
need
howev
prospect
valid
larg
ard
popul
pulmonari
arteri
hypertens
pah
frequent
find
ard
patient
may
provid
prognost
inform
direct
measur
pulmonari
arteri
pressur
mean
pulmonari
arteri
cathet
invas
contrast
ct
measur
pulmonari
arteri
trunk
diamet
may
provid
noninvas
estim
pulmonari
arteri
pressur
beiderlinden
et
al
carri
studi
mechan
ventil
ard
patient
admit
referr
centr
patient
underw
pulmonari
arteri
catheter
chest
ct
admiss
patient
pah
assess
right
heart
catheter
pulmonari
arteri
trunk
diamet
mm
assess
chest
ct
poor
sensit
specif
respect
predict
moderatesever
pah
posit
predict
valu
neg
predict
valu
diagnosi
pah
ct
measur
pulmonari
arteri
trunk
diamet
incorrect
patient
author
conclud
chest
ct
unreli
clinic
tool
predict
pulmonari
arteri
pressur
ard
patient
aliard
character
permeabl
oedema
may
aggrav
fluid
load
groeneveld
verheij
studi
consecut
patient
sepsisinduc
aliard
mv
direct
injuri
e
pneumonia
extrapulmonari
sourc
fluid
load
crystalloid
colloid
lung
protein
permeabl
pulmonari
leak
index
assess
galabel
transferrin
tclabel
red
blood
cell
extravascular
lung
water
evlw
intrathorac
pulmonari
blood
volum
itbvpbv
also
measur
thermaldy
dilut
index
permeabl
ratio
evlwitbv
evlwpbv
alway
poorli
correl
pulmonari
leak
index
conclud
ratio
imperfect
measur
increas
protein
permeabl
independ
fluid
statu
colloid
osmot
pressur
record
pv
curv
respiratori
system
ard
patient
provid
import
physiolog
understand
respiratori
system
major
drawback
muscl
paralysi
requir
thu
limit
clinic
use
measur
decailliot
colleagu
studi
feasibl
record
pv
curv
without
muscl
paralysi
haemodynam
stabl
ard
patient
pv
curv
obtain
zero
peep
cmh
peep
fio
apnoeic
sedat
neuromuscular
blockad
employ
random
order
two
patient
fluid
resuscit
given
apnoeic
sedat
high
level
agreement
linear
part
pv
curv
upper
inflect
point
lower
inflect
point
obtain
five
patient
oesophag
balloon
insert
high
agreement
also
obtain
chest
wall
complianc
author
conclud
pv
curv
obtain
apnoeic
sedat
altern
muscl
paralysi
level
intraindividu
variabl
indic
pv
curv
without
paralysi
use
caution
clinic
set
patient
ard
high
vdvt
ratio
patient
mechan
ventil
proper
condit
inspir
ga
commonli
perform
heat
moistur
exchang
hme
heat
humidifi
hh
hme
howev
contribut
ad
instrument
dead
space
compromis
alveolar
ventil
moran
cowork
analys
effect
substitut
hme
hh
ard
patient
intervent
without
chang
clinic
adjust
ventil
paramet
induc
paco
decreas
mmhg
mmhg
p
expect
author
also
studi
effect
progress
reduct
vt
hh
ventil
keep
paco
unchang
vs
mmhg
strategi
allow
signific
reduct
vt
vs
mlkg
predict
bodi
weight
p
pplat
vs
cmh
p
physiolog
vd
vs
ml
p
signific
increas
respiratori
system
complianc
vs
mlcmh
p
author
conclud
substitut
hme
hh
maintain
isocapn
condit
reduc
vt
improv
respiratori
system
complianc
suggest
less
overdistens
breath
pure
oxygen
may
caus
resorpt
atelectasi
loss
aerat
lung
volum
increas
intrapulmonari
shunt
blood
aboab
et
al
examin
group
aliard
patient
ventil
averag
vt
mlkg
impact
oxygen
breath
derecruit
four
combin
peep
fio
studi
random
order
period
min
peep
fio
signific
decreas
recruit
volum
pao
fio
ratio
observ
end
ventil
period
peep
fio
vs
ml
p
vs
mmhg
p
respect
author
conclud
derecruit
occur
aliard
patient
ventil
low
peep
fio
prevent
high
peep
level
articl
accompani
editori
comment
hedenstierna
mechan
explain
improv
ga
exchang
patient
hypoxaem
respiratori
failur
chang
supin
prone
posit
includ
alveolar
recruit
andor
redistribut
inspir
ga
unknown
whether
mechan
may
influenc
outcom
lemasson
cowork
perform
retrospect
analysi
studi
relationship
ga
exchang
respons
first
prone
posit
session
outcom
found
lack
ga
exchang
improv
increas
pao
fio
signific
outcom
predictor
increas
risk
death
nevertheless
associ
disappear
chang
oxygen
day
day
taken
account
author
conclus
popul
import
predictor
mortal
underli
ill
year
sever
manuscript
publish
field
deal
broad
spectrum
interest
noninvas
ventil
physiolog
patientventil
interact
wean
due
high
number
recent
public
document
benefit
expand
indic
noninvas
mechan
ventil
niv
gain
lot
interest
medic
world
past
year
howev
actual
use
everyday
life
still
well
explor
prospect
survey
french
icu
demoul
et
al
examin
chang
niv
util
compar
previou
studi
perform
year
earlier
total
patient
receiv
ventilatori
support
studi
period
overal
niv
use
increas
icu
patient
requir
ventilatori
assist
without
endotrach
intub
icu
admiss
show
clear
rise
use
niv
period
particular
signific
increas
observ
acuteonchron
respiratori
failur
de
novo
respiratori
failur
niv
basic
never
use
patient
coma
success
rate
remain
unchang
compar
studi
perform
sinc
larger
number
patient
treat
niv
proport
patient
success
treat
french
icu
increas
significantli
period
patient
receiv
ventilatori
support
appli
niv
great
attent
paid
risk
techniqu
particular
unduli
delay
time
endotrach
intub
demoul
et
al
companion
paper
investig
whether
risk
benefit
niv
differ
patient
de
novo
respiratori
failur
cardiogen
pulmonari
oedema
cpe
acuteonchron
respiratori
failur
aoc
adjust
diseas
sever
data
obtain
abovement
survey
outcom
compar
endotrach
intub
without
use
niv
success
niv
independ
associ
surviv
de
novo
cpeaoc
group
decreas
risk
nosocomi
pneumonia
observ
latter
group
shorter
icu
stay
convent
ventil
use
firstlin
treatment
demonstr
group
niv
failur
associ
icu
mortal
de
novo
group
author
rais
note
caution
appli
niv
indic
studi
confirm
hand
niv
consid
firstlin
ventilatori
treatment
aoc
cperel
acut
respiratori
failur
one
key
issu
appli
niv
obtain
good
toler
mode
ventil
without
frequent
intervent
oper
battisti
et
al
evalu
feasibl
use
knowledgebas
system
design
automat
titrat
pressur
support
ps
order
maintain
patient
comfort
zone
algorithm
employ
adapt
level
ps
continu
monitor
patient
data
pursu
goal
keep
patient
zone
defin
respiratori
rate
bpm
tidal
volum
minimum
threshold
set
oper
accord
patient
bodi
weight
endtid
expiratori
co
mmhg
physiolog
studi
automat
system
appli
min
initi
startup
convent
ps
brief
period
closedloop
mode
well
toler
minut
ventil
kept
constant
respiratori
rate
significantli
drop
preniv
valu
also
paco
significantli
decreas
subgroup
hypercapn
patient
preliminari
data
suggest
automat
adjust
system
may
use
niv
valid
futur
clinic
studi
niv
convent
mv
import
optim
patient
comfort
reduc
work
breath
final
achiev
good
match
patient
respiratori
effort
ventil
deliv
breath
follow
three
paper
deal
issu
two
problem
secret
remov
rehabilit
thill
et
al
assess
first
time
incid
real
life
patientventil
asynchroni
intub
patient
patient
prospect
studi
soon
abl
trigger
ventil
breath
either
ps
assistcontrol
ventil
variou
type
asynchroni
defin
e
doubl
trigger
ineffect
trigger
autotrigg
short
prolong
cycl
asynchroni
detect
base
flow
airway
pressur
signal
analyz
two
blind
investig
defin
number
asynchroni
event
divid
total
respiratori
rate
comput
sum
number
ventil
cycl
wast
effort
signific
asynchroni
e
respiratori
effort
doubl
trigger
common
acv
differ
ps
found
ineffect
trigger
latter
associ
less
sensit
inspiratori
trigger
higher
level
ps
higher
tidal
volum
ph
high
incid
asynchroni
also
associ
longer
durat
mv
therefor
conclud
patientventil
asynchroni
quit
common
assist
mode
ventil
optim
ventilatori
set
may
reduc
occurr
mismatch
well
known
mechan
ventil
patient
resist
elast
respiratori
system
may
vari
consider
time
time
variat
may
chang
level
assist
ps
proport
assist
ventil
pav
result
assist
patientventil
asynchroni
andor
increas
inspiratori
muscl
effort
kondili
et
al
studi
physiolog
short
tem
effect
respiratori
motor
output
newli
develop
softwar
use
pav
pav
automat
adjust
flow
volum
gain
factor
repres
alway
constant
fraction
measur
valu
resist
elast
sedat
patient
respiratori
workload
artifici
increas
pav
ps
although
mode
minut
ventil
preserv
load
applic
pav
patient
abl
maintain
constant
minut
ventil
statist
signific
less
inspiratori
effort
ps
addit
pav
index
neuroventilatori
coupl
remain
rel
independ
load
magnitud
load
induc
tidal
volum
reduct
breath
frequenc
increas
significantli
smaller
ps
clearli
studi
need
examin
respons
sustain
load
chang
establish
whether
pav
may
influenc
clinic
outcom
volta
cowork
assess
observ
shortterm
studi
hypothesi
differ
level
fio
may
modul
respiratori
drive
dyspnea
patient
ventil
ps
acut
respiratori
failur
found
respiratori
drive
p
modul
vari
fio
sinc
hyperoxaemia
fio
associ
decreas
p
dyspnea
breath
frequenc
minut
ventil
reduct
respiratori
drive
statist
relat
improv
dyspnea
even
sao
sao
higher
suggest
direct
influenc
pao
respiratori
drive
sinc
scientif
evid
prolong
exposur
hyperoxaemia
result
demonstr
pulmonari
toxic
pao
mmhg
author
suggest
moder
level
hyperoxaemia
may
reduc
need
sedat
patient
dyspnea
discomfort
mv
may
use
deliv
true
ventilatori
support
also
certain
instanc
rehabilit
tool
multicentr
control
studi
clini
cowork
random
tracheotom
patient
wean
mv
receiv
usual
chest
physiotherapi
control
intrapulmonari
percuss
ventil
ipv
via
tracheotomi
tube
addit
previou
rehabilit
treatment
ipv
ventilatori
techniqu
deliv
burst
highflow
respiratori
ga
lung
high
respiratori
rate
ventil
continu
posit
pressur
maintain
highveloc
percuss
inflow
open
airway
might
enhanc
mobil
intrabronchi
secret
day
treatment
patient
intervent
group
significantli
better
improv
oxygen
rate
higher
maxim
expiratori
pressur
followup
lower
incid
pneumonia
major
side
effect
observ
use
ipv
physiolog
mechan
lead
posit
result
directli
investig
therefor
studi
need
assess
efficaci
ipv
especi
critic
ill
patient
trauma
patient
respiratori
distress
need
diagnos
earli
multicentr
cohort
patient
blunt
penetr
trauma
care
prehospit
mobil
icu
raux
et
al
assess
role
respiratori
rate
rr
spo
predict
death
injuri
sever
score
iss
trauma
relat
injuri
sever
score
triss
calcul
systol
arteri
blood
pressur
heart
rate
glasgow
coma
scale
record
patient
rr
spo
whatev
manner
express
rr
spo
continu
five
class
dichotom
none
signific
predict
mortal
trissn
author
conclud
rr
spo
add
signific
valu
variabl
predict
mortal
sever
trauma
patient
paper
prompt
us
reflect
often
rr
spo
disregard
extrahospit
manag
acut
trauma
wean
mv
still
import
aspect
icu
care
account
larg
proport
human
econom
resourc
adopt
standard
approach
consist
among
issu
measur
wean
index
becam
standard
practic
icu
order
expedit
process
ratio
frequenc
tidal
volum
f
v
consid
use
index
clinic
practic
assess
ventilatori
endur
import
prerequisit
success
wean
vassilakopoulo
et
al
explor
use
deriv
index
endur
e
mean
inspiratori
airway
pressur
control
ventil
maximum
inspiratori
pressur
p
mip
mechan
ventil
patient
use
test
perform
variou
indic
employ
prospect
valid
previous
deriv
threshold
valu
combin
two
indic
e
f
v
p
mip
abl
accur
predict
wean
outcom
provid
prognost
inform
offer
either
index
alon
particular
prospect
valid
show
chosen
cutoff
point
sensit
specif
correct
classif
combin
also
superior
index
alon
pathophysiolog
underli
wean
failur
complex
rel
weight
differ
factor
involv
complet
understood
particular
indic
propos
relat
assess
function
respiratori
pump
andor
ga
exchang
littl
emphasi
place
far
cardiac
function
particular
volum
statu
mekontsodessap
et
al
investig
role
btype
natriuret
peptid
bnp
power
marker
cardiac
dysfunct
wean
process
one
hundr
two
patient
prospect
recruit
consid
readi
undergo
wean
trial
bnp
measur
end
logist
regress
analysi
identifi
high
bnp
level
trial
product
airway
pressur
breath
frequenc
independ
risk
factor
wean
failur
interestingli
subset
patient
wean
process
fail
succeed
later
occas
diuret
therapi
decreas
bnp
level
record
time
first
attempt
given
bnp
predictor
left
ventricular
dysfunct
plasma
level
correl
left
ventricular
fill
pressur
author
conclud
hormon
could
use
guid
therapi
manag
acut
left
ventricular
failur
fluid
overload
wean
among
wean
indic
f
v
frequent
use
clinic
practic
past
year
base
studi
publish
year
use
index
recent
challeng
accp
task
forc
conclud
metaanalysi
f
v
reliabl
predict
wean
outcom
tobin
jubran
extract
data
studi
use
index
wean
predictor
attempt
determin
whether
variat
reliabl
f
vt
explain
spectrum
testreferr
bia
reflect
variat
pretest
probabl
success
matter
fact
metaanalysi
statist
valid
free
signific
heterogen
author
found
mark
heterogen
pretest
probabl
success
outcom
among
studi
metaanalysi
also
enter
data
accp
task
forc
bayesian
model
use
preprob
test
preval
success
oper
point
found
posttest
probabl
success
close
correl
valu
predict
origin
studi
r
posit
predict
valu
r
neg
predict
valu
averag
sensit
consid
precis
measur
screeningtest
reliabl
averag
specif
thu
contrari
conclus
reach
accp
task
forc
demonstr
f
v
index
reliabl
screen
test
success
wean
paper
accompani
editori
connor
complex
mathemat
procedur
paper
might
obscur
averag
reader
main
point
studi
true
tobin
jubran
reevalu
valu
f
v
accord
editori
paper
also
ask
us
chang
way
think
process
wean
f
v
index
thought
screen
test
high
sensit
rel
low
specif
therefor
employ
earli
cours
mv
identifi
patient
soon
possibl
breath
appli
confirmatori
test
thereaft
increas
specif
combin
test
reduc
number
fals
posit
model
may
prove
use
minim
time
ventil
reduc
discomfort
risk
continu
intub
patient
readi
wean
